Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ependymomas.

Sajeel Chowdhary1, Myke R Green, Marc Chamberlain

  • 1Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center, University of South Florida, Neuro-Oncology Program, 12902 Magnolia Drive, Tampa, FL 33612, USA.

Current Treatment Options in Neurology
|September 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumors.

Investigational new drugs·2026
Same author

Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review.

Frontiers in oncology·2025
Same author

Artificial Intelligence-Driven Telehealth Framework for Detecting Nystagmus.

Cureus·2025
Same author

A pilot survey into the landscape of neuro-oncology care in the community.

The oncologist·2025
Same author

Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer.

Journal for immunotherapy of cancer·2025
Same author

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

Neuro-oncology advances·2024
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Optimal ependymoma management involves surgical resection for improved survival. Complete resection is key, with reoperation for residual disease. Radiotherapy and chemotherapy roles are specific, especially for recurrent or pediatric cases.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Pediatric Oncology

Background:

  • Ependymomas are tumors of the central nervous system.
  • Optimal management strategies are crucial for patient outcomes.

Purpose of the Study:

  • To outline current best practices for ependymoma management.
  • To discuss the roles of surgery, radiotherapy, and chemotherapy.

Main Methods:

  • Surgical resection and evaluation of central nervous system involvement.
  • Cerebrospinal fluid cytology and craniospinal contrast-enhanced MRI.
  • Consideration of reoperation for residual disease.

Main Results:

  • Complete surgical resection significantly improves survival.

Related Experiment Videos

  • Limited-field radiotherapy is used for residual disease when surgery is not an option.
  • Craniospinal irradiation's role in local disease is controversial.
  • Adjuvant chemotherapy has no clear role; salvage chemotherapy is used for recurrent disease in non-surgical candidates.

    • Conclusions:

    • Complete resection is the cornerstone of ependymoma management.
    • Treatment decisions depend on residual disease, patient age, and recurrence status.
    • Further research is needed to clarify the roles of radiotherapy and chemotherapy.